Google
CMND — CLEARMIND MEDICINE INC. COMMON SHARES (Healthcare >> Biotechnology)
CMND FAQ
What is CMND's ROE?
CLEARMIND MEDICINE INC. COMMON SHARES reports a Return on Equity (ROE) of -80.62%.
What is CMND's dividend yield?
CLEARMIND MEDICINE INC. COMMON SHARES offers a dividend yield of 0.00%.
What is CMND's Deepscope Quality Score?
Deepscope rates CMND's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CMND?
Deepscope's AI Timing Score for CMND is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CMND belong to?
CLEARMIND MEDICINE INC. COMMON SHARES is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.98
Price
1.07
(36.77%)
Day Change
|
|
|---|
CMND, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 87 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.98 |
| PBV / Sector |
0.36 / 4.63
GREAT
|
| Earning Per Share | -8.85 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
18.03 M
GREAT
|
| Average 1W Daily Value |
34.13 M
GREAT
|
| Timing Factors |
|
85% |
| Financial Health |
|
39% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:29 |
| Symbol | CMND |
| Name | CLEARMIND MEDICINE INC. COMMON SHARES |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 1.02 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2.99 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5
Phone: 973 536 1016
Website: https://www.clearmindmedicine.com
Sector: Healthcare >> Biotechnology
Description: Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
